MTY Food Group Inc header image

MTY Food Group Inc

MTY

Equity

ISIN null / Valor 1639382

Toronto Stock Exchange (2026-04-10)
CAD 38.85-3.86%

MTY Food Group Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

MTY Food Group Inc. is a prominent player in the quick-service and casual dining restaurant industry, with a history spanning over four decades. The company is known for its strategic approach to growth, which includes the acquisition of diverse restaurant brands and the formation of strategic alliances. This strategy has enabled MTY to expand its portfolio and enhance its market presence. MTY Food Group operates a wide array of restaurant concepts, catering to various consumer preferences and dining experiences. The company's focus on innovation and strategic expansion has solidified its position as a significant entity in the food service sector.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (23.03.2026):

MTY Food Group Inc reported third-quarter fiscal 2025 (Q3-2025) results: revenue of $297.0 million (up ~1% year-over-year) and normalized adjusted EBITDA of $74.0 million (up 3%). Net income attributable to owners declined to $27.9 million, or $1.22 per diluted share, driven partly by $6.2 million of impairment charges. The company ended the quarter with 7,061 locations, declared a quarterly dividend of $0.33 per share, and reported $39.0 million of operating cash flow for the quarter.

Key financials

Revenue: $297.0M (+1% y/y). Normalized adjusted EBITDA: $74.0M (+3% y/y). Net income attributable to owners: $27.9M (Q3-2024: $34.9M). Diluted EPS: $1.22 (Q3-2024: $1.46). Adjusted EPS: $1.19 (unchanged vs Q3-2024).

Profitability and segments

Segment profit totaled $73.2M (+2%). Franchise segment normalized adjusted EBITDA fell 2% to $56.0M. Corporate segment normalized adjusted EBITDA rose to $13.1M (boosted by a $5.8M Employee Retention Credit), with margin improving to ~11% from 8%. Food processing, distribution & retail revenue grew 18% to $47.6M, but its normalized adjusted EBITDA declined to $4.9M due to higher food costs.

Cash flow and balance sheet

Cash flows from operations: $39.0M (Q3-2024: $66.4M), largely affected by timing of receivables tied to SAP implementation and higher taxes paid. Free cash flows net of lease payments: $25.8M (Q3-2024: $49.3M); free cash flow per diluted share: $1.13. Cash on hand: $37.1M. Long-term debt: $638.9M; company repaid $30.4M in the quarter and $65.6M net since Q3-2024. Revolving facility availability remains in place (authorized $900M; draws noted at quarter-end).

Network and sales trends

System sales about $1.46B for the quarter (modest y/y decline). Net store openings: +15 in Q3-2025 (96 openings, 81 closures), ending with 7,061 locations (58% US, 35% Canada, 7% International). Same-store sales declined 1.6% (improved sequentially from -1.9% in Q2-25); Canada -0.3%, US -2.5%, International +0.8%. Digital sales rose 1% to $273.4M.

One-time items and non-GAAP drivers

Normalized adjusted EBITDA benefited from a $5.8M U.S. Employee Retention Credit; excluding that, normalized adjusted EBITDA would have modestly declined. Net income was reduced by $6.2M in impairment charges on intangible assets across several brands. SAP implementation-related timing impacted working capital and cash flows.

Capital allocation and shareholder return

Declared quarterly dividend of $0.33 per share payable November 14, 2025 (record date Nov 4, 2025). No share repurchases in the quarter. Management continues debt repayment and expects lower capex to support free cash flow generation in 2025.

Outlook and risks

Management reports sequential banner improvements (notably Cold Stone Creamery and Wetzel’s Pretzels) and a strong pipeline for new locations, while cautioning that macroeconomic and policy risks (e.g., prolonged U.S. government shutdown affecting SBA funding, SNAP benefit disruptions, tariffs) could weigh on openings and sales. Management expects stable normalized adjusted EBITDA margins across segments and continued focus on unit growth, efficiencies and ERP rollout execution. Summarized from source with an LLMView Source

Key figures

-0.72%1Y
-36.2%3Y
-30.1%5Y

Performance

32.4%1Y
30.3%3Y
31.5%5Y

Volatility

Market cap

641 M

Market cap (USD)

Daily traded volume (Shares)

77,006

Daily traded volume (Shares)

1 day high/low

45.86 / 45.28

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Intellia Therapeutics Inc
Intellia Therapeutics Inc Intellia Therapeutics Inc Valor: 32256913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.46%USD 13.49
LG Display JH
LG Display JH LG Display JH Valor: 1908212
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.15%USD 4.49
Salesforce Inc
Salesforce Inc Salesforce Inc Valor: 1755645
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.45%USD 164.96
FactSet Research Systems Inc
FactSet Research Systems Inc FactSet Research Systems Inc Valor: 468306
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.90%USD 211.60
Microvast Holdings Inc
Microvast Holdings Inc Microvast Holdings Inc Valor: 112854187
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.10%USD 1.65
Genflow Biosciences Plc
Genflow Biosciences Plc Genflow Biosciences Plc Valor: 115917310
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%GBP 0.019
Cizzle Biotechnology Holdings PLC
Cizzle Biotechnology Holdings PLC Cizzle Biotechnology Holdings PLC Valor: 111334752
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.08%GBP 0.024
Jenoptik AG
Jenoptik AG Jenoptik AG Valor: 43359082
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.15%EUR 30.82
IONOS Group SE
IONOS Group SE IONOS Group SE Valor: 124525998
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.08%EUR 23.68
NetApp Inc
NetApp Inc NetApp Inc Valor: 3906336
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.27%USD 95.93